Trillium.BiO

Doing New Things Together

07/30/2026

We’re proud to be recognized by the Moxie Award’s as a finalist for D.C.’s Healthcare Company of the Year.

At TrilliumBiO, we’re creating solutions that empower physicians and bring clarity to patients who’ve been overlooked by traditional pathways. Thank you to the Moxie Awards for celebrating boldness in healthcare innovation.

07/29/2026

What’s one thing you would tell patients with LAM (Lymphangioleiomyomatosis) and one thing you would tell clinicians?

We asked Beth Hull Daugherity to answer both. Her answers are worth hearing, for anyone touched by this disease and for those diagnosing and treating it. 🫁

07/23/2026

We’re heading to the TSC World Conference next week!

Join us as we engage with leaders across the TSC community to discuss how TrilliumBiO is advancing diagnostic innovation and improving access to care for individuals living with tuberous sclerosis complex.

Our team is looking forward to connecting!

07/22/2026

Myth or fact? We're breaking down common misconceptions about neurodegenerative diseases.🧠

Understanding what's actually true can change how we support the people living with these conditions.

07/21/2026

We’re excited to participate in the VA Healthcare Summit in Maryland!

Visit us to learn how TrilliumBiO is building a comprehensive diagnostic pathway that supports veterans across the neurodegenerative disease continuum.

Our team will be available throughout the summit to walk you through our approach and discuss how we’re working to close critical gaps in veteran healthcare access.

07/20/2026

We’re proud to share that has recognized our CMO, Dr. Aamir Ali, as one of its 2026 Top Doctors!

His firsthand experience as a practicing physician guides TrilliumBiO’s mission to identify and close critical gaps in the healthcare pathway.

07/16/2026

Neurodegenerative diseases affect millions of people worldwide, and the numbers behind them tell a powerful story. Today, we’re highlighting key statistics that shape the landscape of Alzheimer’s disease, Parkinson’s disease, and other related conditions.

Beyond expanding our neurology offerings to make care more accessible, we’re committed to advancing education as well by providing information that supports individuals, families, and clinicians as they navigate these conditions.

Swipe to learn more➡️

07/15/2026

That’s a wrap on !

Thank you to everyone who stopped by booth #847 to discuss our neurodegenerative disease waypoint companion app & Alzheimer’s disease biomarker portfolio. Your questions and insights were truly helpful.

The conversation doesn’t have to end here. If we connected at AAIC (or missed each other!), reach out. We’d love to keep talking about how TrilliumBiO can support your work in neurodegenerative disease diagnostics.

Diagnostics

07/14/2026

Great catching up with Allitia DiBernardo, MD, a member of our neurodegenerative disease advisory board, at .

Conversations like these are exactly why we're here: bridging diagnostics and clinical trials to move care forward.

Looking forward to picking things back up tomorrow.

07/13/2026

Great conversations so far about early detection and the diagnostic delay so many families face with Alzheimer's disease and related neurodegenerative diseases.

Stop by Booth #847 if you're at in London!

Address

9808 Medical Center Drive, Suite 330
Rockville, MD
20850

Telephone

+18882612812

Website

http://TrilliumBio.com/

Alerts

Be the first to know and let us send you an email when Trillium.BiO posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Trillium.BiO:

Shortcuts

Want your practice to be the top-listed Clinic in Rockville?